Skip to main content

GEODE CAPITAL MANAGEMENT, LLC

Position in APGE — Apogee Therapeutics, Inc.

CIK 1214717 BOSTON, MA

Position in APGE

as of Jun 30, 2026 · filed Aug 12, 2026
Position Value
$174,522,429
+$72,063,214 QoQ
Shares Held
1,314,868
+8.0% QoQ
Ownership
1.74%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#16
of 285 holders
Holding Since
Sep 2023
12 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in APGE Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

GEODE CAPITAL MANAGEMENT, LLC holds $21,877,415,676 across 520 Biotechnology names. APGE ranks #31 (0.8% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in APGE

Export CSV
12 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $174,522,429 1,314,868
2026-03-31 $102,459,215 1,217,289
2025-12-31 $79,939,734 1,059,085
2025-09-30 $35,447,224 892,203
2025-06-30 $33,990,098 782,641
2025-03-31 $31,221,564 835,695
2024-12-31 $36,969,918 816,113
2024-09-30 $48,392,302 823,839
2024-06-30 $29,152,880 740,861
2024-03-31 $50,570,044 761,024
2023-12-31 $12,334,727 441,472
2023-09-30 $8,546,326 401,236